Roquefort Therapeutics PLC
LSE:ROQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
UK |
|
M
|
Murata Manufacturing Co Ltd
OTC:MRAAF
|
JP |
|
H
|
Hanza AB
STO:HANZA
|
SE |
|
Santos Ltd
ASX:STO
|
AU |
|
Australian Silica Quartz Group Ltd
ASX:ASQ
|
AU |
|
S
|
Shinyoung Wacoal Inc
KRX:005800
|
KR |
|
K
|
Ko Ja Cayman Co Ltd
TWSE:5215
|
TW |
|
Heritage Foods Ltd
NSE:HERITGFOOD
|
IN |
|
H
|
Hap Seng Plantations Holdings Bhd
KLSE:HSPLANT
|
MY |
|
W
|
World Fuel Services Corp
XBER:WFK
|
US |
|
A
|
American National Bankshares Inc
XBER:NBR
|
US |
|
Tata Steel Ltd
NSE:TATASTEEL
|
IN |
|
S
|
SMU SA
SGO:SMU
|
CL |
|
International Game Technology PLC
NYSE:IGT
|
UK |
|
HCR Co Ltd
SSE:688500
|
CN |
Income Statement
Earnings Waterfall
Roquefort Therapeutics PLC
Income Statement
Roquefort Therapeutics PLC
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||
| Cost of Revenue |
(0)
|
0
|
0
|
(0)
|
|
| Gross Profit |
(0)
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
|
| Operating Income | |||||
| Operating Expenses |
(1)
|
(2)
|
(2)
|
(1)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(1)
|
|
| Research & Development |
0
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
(0)
|
0
|
|
| Operating Income |
(1)
N/A
|
(2)
-220%
|
(2)
-18%
|
(1)
+42%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
0
|
0
|
0
|
(0)
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-78%
|
(2)
-18%
|
(1)
+37%
|
|
| Net Income | |||||
| Tax Provision |
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(2)
|
(2)
|
(1)
|
|
| Net Income (Common) |
(1)
N/A
|
(2)
-76%
|
(2)
-8%
|
(1)
+44%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.01
N/A
|
|